Johnson & Johnson's Ottava robotic surgery platform has a differentiated architecture (arms integrated into the table) that reduces operating room friction, while the robotic surgery market has only 8% penetration and is fast-growing. J&J expects its robotics business to become materially significant towards the end of the decade and aims to become a leader in surgical robotics.